See with Certainty

Our vision is to make healthcare accessible to everyone so that we can all enjoy a healthy life.

We harness the power of AI to provide affordable clinical support tools that make disease screening easy, anytime, anywhere.

Setting the new benchmark in accurate and efficient patient care

Eyetelligence is a MedTech company, innovating to set the new benchmark in accurate and efficient patient care. We empower people with advanced AI and automation, using the eye as the gateway to detect and prevent diseases in the earliest stages.

Our flagship product, Eyetelligence Assure, is already supporting optometrists in the screening and management of three major eye diseases that cause preventable blindness. This same technology is also able to detect signs of up to 139 additional eye diseases.

As we continue to work towards our goal, we are now finalising an AI model that can assess microvascular health of the eye, using it as an accurate risk assessment tool for the vascular health of a patient, all from a digital fundus image.

History

Eyetelligence is the result of a decade of intensive research, based on the initial AI tool known as Eyegrader, developed by Professor Mingguang He and his colleagues in China.

Professor He joined CERA (Centre for Eye Research Australia) in 2015, and Eyetelligence Pty Ltd was established in Australia in 2019, to further develop and commercialise the AI decision support software.

Our Team

ming-be.jpg
Chief Medical Officer

Professor Mingguang He

Professor Mingguang He, an ophthalmologist, is the current Professor of Ophthalmic Epidemiology at the University of Melbourne and CERA. He was awarded an NHMRC leadership fellowship in 2019. He is a world-renowned expert in the development and application of AI systems in ophthalmology, attracting grant support from the BUPA Health Foundation, Google impact challenge, MRFF Rapid Applied Research Translational Grant and an NHMRC partnership grant. His AI research has led to original articles published in JAMA, Diabetes Care, Ophthalmology and invited editorials. Professor He has international leadership experience as the founding president of the Asia Pacific Tele-Ophthalmology Society. He has also established collaboration with industry bodies such as Apple, Google and USA FDA.
zongyuan.jpg
Chief Research Officer

Dr. Zongyuan Ge

Dr. Zongyuan Ge conducts interdisciplinary research at the boundary between artificial intelligence, computer-aided diagnosis, biomedical engineering, medical imaging and machine learning, and is a multi-award-winning medical information science and technology entrepreneur. He is the Chief Research Officer of the company, and received the 5M MRFF AI grant together with Eyetelligence.
grote.jpg
Chief Executive Officer

Rainer Grote

An MBA qualified executive with a 25-year track record, Rainer Grote brings diverse cultural and industry experience gained from multi-national and entrepreneurial organisations within health, medtech and AI across APAC, Europe, USA and Asia.
jason-su.png
Chief Strategy Officer

Jason Sun

Jason Sun is an experienced healthcare management professional, currently involved in international engagement and business development for the Australian healthcare industries in Greater China and other Asian growth markets.
kim.jpg
Chief Financial Officer

Kim Walker

Kim is an experienced executive / consultant with a proven track record in strategy and commercialisation. Skilled in Business and Commercialisation Planning, and the subsequent implementation of strategic change within organisations.
jenni.jpg
Chief Legal Officer

Jenny Wang

Jenny Wang is a Director for a large Australian law firm and is an expert in risk and international contract law.
ming-be.jpg
Chief Medical Officer

Professor Mingguang He

Professor Mingguang He, an ophthalmologist, is the current Professor of Ophthalmic Epidemiology at the University of Melbourne and CERA. He was awarded an NHMRC leadership fellowship in 2019. He is a world-renowned expert in the development and application of AI systems in ophthalmology, attracting grant support from the BUPA Health Foundation, Google impact challenge, MRFF Rapid Applied Research Translational Grant and an NHMRC partnership grant. His AI research has led to original articles published in JAMA, Diabetes Care, Ophthalmology and invited editorials. Professor He has international leadership experience as the founding president of the Asia Pacific Tele-Ophthalmology Society. He has also established collaboration with industry bodies such as Apple, Google and USA FDA.
zongyuan.jpg
Chief Research Officer

Dr. Zongyuan Ge

Dr. Zongyuan Ge conducts interdisciplinary research at the boundary between artificial intelligence, computer-aided diagnosis, biomedical engineering, medical imaging and machine learning, and is a multi-award-winning medical information science and technology entrepreneur. He is the Chief Research Officer of the company, and received the 5M MRFF AI grant together with Eyetelligence.
grote.jpg
Chief Executive Officer

Rainer Grote

An MBA qualified executive with a 25-year track record, Rainer Grote brings diverse cultural and industry experience gained from multi-national and entrepreneurial organisations within health, medtech and AI across APAC, Europe, USA and Asia.
jason-su.png
Chief Strategy Officer

Jason Sun

Jason Sun is an experienced healthcare management professional, currently involved in international engagement and business development for the Australian healthcare industries in Greater China and other Asian growth markets.
kim.jpg
Chief Financial Officer

Kim Walker

Kim is an experienced executive / consultant with a proven track record in strategy and commercialisation. Skilled in Business and Commercialisation Planning, and the subsequent implementation of strategic change within organisations.
jenni.jpg
Chief Legal Officer

Jenny Wang

Jenny Wang is a Director for a large Australian law firm and is an expert in risk and international contract law.

Want to learn more? Get in touch today.